Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Fedratinib (TG101348) inhibits proliferation of a human erythroblast leukemia (HEL) cell line that harbors the JAK2V617F mutation
selective and orally bioavailable class-I PI3K kinase inhibitor
InChi: InChI=1S/C12H21NO8S/c1-10(2)18-7-5-16-12(6-17-22(13
23)24/h5-7
GYKI-47261 dihydrochloride um Channel inhibitor 2 Fedratinib (TG101348) inhibits proliferation ofGYKI 47261 dihydrochloride is a competitive, orally active, and selective AMPA receptor antagonist with an IC50 of 2. 5 M. GYKI 47261 has broad spectrum anticonvulsive activity and neuroprotective effects. GYKI 47261 dihydrochloride is also a potent inducer of CYP2E1. Product information CAS Number: 1217049 32 5 Molecular Weight: 395. 71 Formula: C18H17Cl3N4 Chemical Name: 4 {12 chloro 5 methyl 4,7,8 triazatricyclo[8. 4. 0. 0,]tetradeca
US$ 404.50
US$ 5670.52
US$ 1824.18
US$ 1601.53
US$ 2600.80
US$ 5714.19
US$ 2754.91